A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma.

PHILADELPHIA, PA — Medicus Pharma Ltd. (Nasdaq: MDCX) issued a clarification of previously reported Phase 2 trial results for ...

Detailed price information for Medicus Pharma Ltd (MDCX-Q) from The Globe and Mail including charting and trades.

Basal Cell Carcinoma: Causes, Symptoms, Diagnosis and Treatment: By Shreoshree Chakrabarty Basal Cell Carcinoma (BCC) is one of the most common skin cancer types, affecting millions globally each year ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally advanced tumors in particular can be difficult to treat surgically. A ...

Basal cell carcinoma has low immunogenicity. Tumor cells express Foxc1 protein (red), which suppresses HLA class I (green) in the tumor cells. Compromised antigen presentation ranks among the top ...

Red light photodynamic therapy (PDT) with 10% aminolevulinic acid (ALA) tamed superficial basal cell carcinoma (BCC) in a phase 3 trial with no new safety concerns. Significantly higher clearance ...

There are three common types of skin cancer in the United States: basal cell carcinoma, squamous cell carcinoma and melanoma. Merkel cell carcinoma is a rare type of skin cancer. Fred Hutch Cancer ...